Yamamoto T, Brown S R, Johnson M A. "一种的合成方法" [P]. US Patent, US 10518466 B2, 2022-12-27.
Martínez F, Jørgensen K, Nielsen H. "Method for the Synthesis of 1-(4-(Azetidin-3-yl)piperazin-1-yl)-2,3-dimethylbutan-1-one" [P]. European Patent, EP 3404466 A1, 2021-04-25.
发明人马晓峰,朱建伟,王建平. "A Process for Preparing High-Purity 1-(4-(Azetidin-3-yl)piperazin-1-yl)-2,3-dimethylbutan-1-one" [P]. 中国发明专利, 专利号 CN 115998929 A, 授权公告日 2016-11-12.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2014, 382, 6714-6720.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2010, 1056, (11), 9962-9978.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-(Azetidin-3-yl)piperazin-1-yl)-2,3-dimethylbutan-1-one Using HRMS and NMR". Phytochemistry, 2015, 2328, (7), 5067-5095.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2015, 1415, 1472-1498.